GSK4418959, PD-1 inhibitor — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-06-22 today
ESTIMATED |
READOUT
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectivene
Phase 1/2 · Neoplasms, Colorectal, Solid Tumor |
GlaxoSmithKline | GSK4418959, PD-1 inhibitor |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|